InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Madan Ajay, Directeur du Développement. Insider active across 1 companies, notably Crinetics Pharmaceuticals, Inc.. In total, 5 filings have been logged. Total volume traded: €417k. The latest transaction was disclosed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations5 total
013,950 shares0
Common Stock
SEC:0001209191-22-015131:0·
€208,71413,411 shares@ €15.56290.0047% mcap75.8% of flow
Common Stock
SEC:0001209191-22-008061·
€208,71413,411 shares@ €15.56290.0047% mcap37.9% of flow
Common Stock
SEC:0001209191-22-008061:0·
€66,469106,383 shares@ €0.62480.0015% mcap24.2% of flow
Common Stock
SEC:0001209191-21-062263·
€66,469106,383 shares@ €0.62480.0015% mcap12.1% of flow
Common Stock
SEC:0001209191-21-062263:0·
5 of 5 declarations
About Madan Ajay
Ajay Madan is the Chief Development Officer at Crinetics Pharmaceuticals, Inc. He is responsible for product development strategy and innovation within the company.
